NCT03392935View on ClinicalTrials.gov

Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Dermatofibroma of Skin
Interventions
DEVICE

1540 nanometer Erbium glass laser

Subjects will receive laser treatment by dermatologist at week 0 and week 4.

Trial Locations (1)

84132

University of Utah Dermatology, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT03392935 - Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas | Biotech Hunter | Biotech Hunter